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Summary
Critical illness is characterised by nutritional and metabolic
disorders, resulting in increased muscle catabolism, fat-free
mass loss, and hyperglycaemia. The objective of the nutri-
tional support is to limit fat-free mass loss, which has neg-
ative consequences on clinical outcome and recovery. Early
enteral nutrition is recommended by current guidelines as
the first choice feeding route in ICU patients. However,
enteral nutrition alone is frequently associated with insuf-
ficient coverage of the energy requirements, and subse-
quently energy deficit is correlated to worsened clinical
outcome. Controlled trials have demonstrated that, in case
of failure or contraindications to full enteral nutrition, par-
enteral nutrition administration on top of insufficient en-
teral nutrition within the first four days after admission
could improve the clinical outcome, and may attenuate fat-
free mass loss. Parenteral nutrition is cautious if all-in-one
solutions are used, glycaemia controlled, and overnutrition
avoided. Conversely, the systematic use of parenteral nu-
trition in the ICU patients without clear indication is not
recommended during the first 48 hours. Specific methods,
such as thigh ultra-sound imaging, 3rd lumbar vertebra-tar-
geted computerised tomography and bioimpedance elec-
trical analysis, may be helpful in the future to monitor
fat-free mass during the ICU stay. Clinical studies are war-
ranted to demonstrate whether an optimal nutritional man-
agement during the ICU stay promotes muscle mass and
function, the recovery after critical illness and reduces the
overall costs.
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Introduction
Patients with critical illness, admitted to the intensive care
unit (ICU) are characterized by a systemic inflammatory
response (SIRS), which triggers metabolic and nutritional
disorders: increased muscle catabolism, lipolysis, in-
sulinoresistance, and hyperglycaemia. These metabolic
changes aim at increasing the synthesis of inflammatory
proteins by the liver, and at furnishing glucose as an energy
source to vital organs (e.g., heart, kidney, etc.). During the
ICU stay, fat-free mass loss is about 400 g/day. In that con-
text, delivering the adequate energy and protein provision
may limit the negative consequences of hypercatabolism
and limit fat-free mass loss (fig. 1). The protection of fat-
Figure 1
Improved clinical outcome with optimised nutrition support and
monitoring in the intensive care unit. Enteral nutrition (EN) alone is
often associated with an insufficient energy provision, leading to
energy deficit; the latter is associated with fat-free mass loss,
increased risk of infections and complications, and increased
mortality. Systematic parenteral nutrition (PN) without appropriate
indication is associated with increased risks of overfeeding,
hyperglycaemia, and promotes infections, hepatic steatosis, liver
disease, hypoglycaemia (as a result of high insulin doses), and
mortality. Optimal nutrition support improves the clinical outcome. It
includes the adequate choice of nutritional support: i) EN in first
line, then together with supplemental parenteral nutrition in case of
failure or contraindication to optimised EN; ii) parenteral nutrition
alone when appropriate with respect to the indications, the
preferred use of ‘all-in-one’ solutions, and the glycaemic control; iii)
the nutritional and metabolic monitoring: adequation of protein/
energy provision towards target, blood glucose and insulin doses
according to on-going protocols. The assessment of fat-free mass
may become the key part of the nutritional management of ICU
patients, but validation studies are needed.
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 1 of 9
free mass is a challenge in ICU patients. As a matter of fact,
the medical environment and the patients in the ICU are
changing: the improvements of medical technology (e.g.,
better mechanical ventilation, infection control and haemo-
dynamic management), ageing, obesity, increased preval-
ence of chronic diseases (cancer, degenerative neurological
diseases, organ insufficiencies, etc.), and sedentary contrib-
ute to it. Patients with pre-existing undernutrition and/or
lean tissues depletion (e.g., sarcopenic obesity, advanced
age, severe chronic diseases) are becoming prevalent. As
these conditions are incompatible with stress-induced cata-
bolism and rapid healing and recovery the prevention of
their onset or worsening is warranted. Therefore, the nutri-
tional support should be considered as a mean of optimiz-
ation of fat-free mass and energy balance during the ICU
stay.
Early enteral nutrition is recommended by current
guidelines as the first choice feeding route in ICU patients
[1]. However, enteral nutrition alone is often unable to fully
cover the nutritional needs of patients [2–3]. The resulting
cumulated energy deficit is associated with a worse clin-
ical outcome [4–7] (fig. 1). Prospective randomised stud-
ies indicate that the administration of parenteral nutrition
to supplement insufficient enteral nutrition within the first
four days post-admission in the patients with failure or con-
traindications to enteral nutrition could improve the clinic-
al outcome [8–9]. The use of parenteral nutrition is safe if
overfeeding and hyperglycaemia are avoided. The optimal
use of parenteral nutrition in the ICU should be based on
the assertion that limiting the energy deficit and preventing
overfeeding would improve the clinical outcome, shorten
the recovery period, and reduce overall costs.
The burden of energy deficit
Numerous studies have shown that enteral nutrition is in-
sufficient to cover energy requirements [2–3]. Analyses
conducted in U.S. [10], Canadian [11], and Swiss [2] hos-
pitals found that a maximum of 52% to 70% of prescribed
calories were actually delivered through enteral nutrition in
the ICU patients. This is the consequence of frequent en-
teral nutrition interruption because of radiologic or endo-
scopic investigations, surgery and technical problems re-
garding nutrition pumps or feeding tubes, gastrointestinal
intolerance [12], and irrelevant medical prescriptions or in-
adequate routine nursing procedures such as repeated gast-
ric residues measurements. The implementation of feed-
ing protocols based on current guidelines was supposed to
improve energy delivery [13], but has failed constantly to
reach the energy target [10, 11]. The use of prokinetics,
such as erythromycin [14], and the suppression of gastric
residues measurements [15] might contribute to improve
energy provision. Optimisation of enteral nutrition in the
ICU remains a great challenge even when a well-trained
and experienced nutrition team is available [2]. The result-
ing energy deficit has been associated with increased mor-
tality, and increased infection rate [4–7], impaired wound
healing [5], adult respiratory distress syndrome, renal fail-
ure, need for surgery, and pressure sores [5]. Energy deficit
also leads to fat-free mass loss, undernutrition [16], and
its related complications, which, in turn, increases global
health care costs [17]. The additional risk of underfeeding
during the ICU stay is further amplified since patients are
frequently undernourished prior to their ICU admission
[18–19]. Whereas some degrees of deficit are probably ac-
ceptable during the first ICU days (around –50 kcal/kcal/kg
[4, 5]), limiting cumulated energy deficit is the key chal-
lenge to prevent the worsening of undernutrition and im-
prove the clinical outcome [20]. When enteral nutrition is
insufficient to cover the energy target, parenteral nutrition
could be a reliable means to match energy requirements
with delivery, and avoid further energy deficit [8].
Supplemental parenteral nutrition and
improved clinical outcome
Supplemental parenteral nutrition to improve energy
provision and nutritional status
The combination of parenteral nutrition with enteral nutri-
tion increases calorie delivery in comparison with enteral
nutrition alone (28 ± 5 vs 20 ± 5 kcal/kg/day, p <0.0001)
[8], suggesting that the combination of enteral nutrition and
parenteral nutrition allows the achievement of the energy
target sooner during critical illness. In a study of 49 un-
dernourished ICU patients with mechanical ventilation, an
increase in serum transthyretin and the Maastricht index,
an assessment tool of nutritional status that incorporates
serum transthyretin and albumin, lymphocyte count, and
percentage of ideal weight, was observed after two weeks
of supplemental parenteral nutrition, whereas no improve-
ment was observed in patients treated with enteral nutrition
or parenteral nutrition alone [21]. This effect could be re-
lated to the optimisation of energy delivery.
Evidence from recent prospective randomised
controlled trials (table 1)
Two prospective, controlled, randomised trials have
provided evidence of the clinical benefit of parenteral nu-
trition in ICU patients [8–9]. The Swiss SPN trial [8] was
conducted in 305 mixed medical-surgical ICU patients (7%
with cardiac arrest, 5% with myocardial infarction) with in-
sufficient enteral nutrition or failure to optimised enteral
nutrition. These represented 12% of the admitted patients
during the study period. The delivery of the 100% of en-
ergy target from day 4 to day 8 by enteral nutrition and
supplemental parenteral nutrition in ICU patients receiving
less than 60% of their energy needs during the first three
days of their ICU stay reduced the number of patients with
nosocomial infections, as well as the duration of mechan-
ical ventilation [8]. In the Early Parenteral Nutrition Tri-
al, Doig et al showed, in 1372 mixed medical-surgical ICU
patients (20% with cardiovascular diseases) with relative
contra-indications to enteral nutrition, no deleterious effect
of early parenteral nutrition provided within the 24 hours
following admission in comparison with standard care at
the physician’s discretion [9]. In the interventional group
receiving parenteral nutrition, patients received parenteral
nutrition during a short time period: a mean of 6.0 days
(95% confidence interval (CI), 5.6–6.4). Early parenteral
nutrition even showed clinical benefits on the duration of
invasive ventilation, 60–day quality of life and body com-
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position [9]. This approach was cost-effective [22]. Im-
proved quality of life and body composition associated
with early parenteral nutrition suggest a positive impact
of optimal nutrition on post-ICU rehabilitation. This rein-
forces the hypothesis that timely individualised nutritional
support is likely to limit fat-free mass loss and to shorten
the recovery phase in ICU patients with preexisting under-
nutrition at admission.
Supplemental parenteral nutrition to reduce enteral
nutrition-associated symptoms
Another approach for promoting supplemental parenteral
nutrition in the ICU is to prevent enteral nutrition-related
side effects. For instance, we have recently showed in a
prospective observational study that diarrhoea was reported
at least one day in 14% of patients during their ICU stay
[23]. There was a clear relationship between enteral nu-
trition providing ≤60% of energy target and diarrhoea on-
set. This suggests that in some patients, the combination
of enteral nutrition and parenteral nutrition may be helpful,
reducing the burden and the cost of managing diarrhoea
(manpower, investigations, treatment).
Summary
In patients with failure, intolerance, or relative contra-in-
dications to enteral nutrition, supplemental parenteral nu-
trition initiated between 24 and 72 hours after admission
could prevent the worsening of energy deficit, and improve
the clinical outcome of ICU patients. Furthermore, sup-
plemental parenteral nutrition could reduce the incidence
of enteral nutrition-related side effects, and their related
costs. When parenteral nutrition is administered, the re-
spect of good clinical practices is mandatory. Calories de-
livery should be adjusted to energy deficit and monitored
daily. In fact the prevention of overfeeding and its related
complications is as important as the limitation of energy
deficit.
Inappropriate use of parenteral
nutrition and risk of complications
Parenteral nutrition has been repeatedly associated with
overfeeding, especially in the 1980s and 1990s, at a period
when it was thought that the more calories was admin-
istered, the better the outcome would be. In 2014, an in-
appropriate use of parenteral nutrition remains associated
with an increased risk of infections [25–28], and liver
metabolic complications [29].
Parenteral nutrition and the risk of overfeeding
It has been extensively demonstrated that parenteral nutri-
tion can induce metabolic disorders, known as “overfeed-
ing”, such as hyperglycaemia, hypertriglyceridemia, liver
steatosis, endocrine dysfunction, impairment of immunity,
infections, and increased mortality [27]. Parenteral nutri-
tion related infectious complications have been linked to
hyperglycaemia, which was not considered a serious issue
before 2001 [27, 30]. Large randomised, controlled, pro-
spective studies have shown that an optimised glycaem-
ic control with the aim to obtain a glycaemia less than
10 mmol/l and avoiding hypoglycaemia reduces mortality
and morbidity [31–32]. Overfeeding has no beneficial im-
pact on the nutritional status, and is deleterious. Hart et al
showed that feeding burned patients at more than their en-
ergy expenditure leads to fat rather fat-free mass accretion
[33]. In summary, overfeeding whatever the route is asso-
ciated with increased complications that increase mortal-
ity, and is not associated to an improvement of nutritional
status and body composition. Therefore, the prevention of
overfeeding is deeply warranted in the ICU.
Parenteral nutrition and infections
Multicentre studies of ICU patients indicate that the use
of parenteral nutrition or its duration is associated with
an increased risk of Candida colonisation or candidemia
[34–35]. However, other independent risk factors of Can-
dida infections have been identified: sepsis, multifocal col-
onisation, and surgery [35]. An Italian multicentre random-
ised study conducted in 33 general ICUs (326 patients)
found that, in the subgroup of patients without septic shock
Table 1: Prospective randomised controlled trials evaluating the clinical outcome of supplemental parenteral nutrition (PN) in intensive care units (ICU) patients. EN,
enteral nutrition; GI, gastrointestinal; PN, parenteral nutrition.
References Patients (n) ICU patients types Study groups Main results Practical messages
TICACOS
[50]
112 Mechanically ventilated
Surgical: 45%
Medical: 55%
EN with an energy target
determined by:
indirect calorimetry (study
group), or according to 25 kcal/
kg/day (control group). EN
supplemented with PN when
required
Trend towards improved
hospital mortality in the study
group, but increased length of
ventilation and ICU stay
Nutritional intervention based
on indirect calorimetry may be
beneficial
EPaNIC
[28]
4640 Surgical: 89%, 60% of cardiac
surgery
Medical: 11%
Glucose load followed by PN
initiation on day 3
vs PN initiation on day 8
PN initiation on day 8: faster
recovery and fewer
complications
Avoid PN in the first 48 hours
of ICU stay, if not indicated
SPN study
[8]
305 Patients receiving <60% of
energy target by day 3
Surgical: 46%
Medical: 54%
Supplemental PN from day 4
to day 8 to reach 100% of
measured energy target vs
standard EN
Supplemental PN: reduction in
nosocomial infections,
antibiotic use, and duration of
mechanical ventilation
Early PN trial
[9]
1372 Surgical: 63%
Medical: 37%
Standard nutrition vs PN within
24 hours if contraindication to
EN
Early PN: fewer days of
invasive ventilation, but similar
60–day mortality and ICU-
hospital lengths of stay
– Accept low energy EN the
first 4 days
– Consider PN if insufficient
EN by day 4
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(n = 142), the administration of parenteral nutrition was
associated with more episodes of severe sepsis or septic
shock than on patients with enteral feeding [36]. In another
study performed in 415 patients with severe sepsis or septic
shock from 454 ICUs from 310 hospitals, the use of par-
enteral nutrition was independently associated with an in-
creased risk of death, after adjustment for patient morbidity
[37]. In trauma patients with a quite good enteral nutrition
tolerance, it was shown that early parenteral nutrition was
associated with an increased infectious morbidity [38].
However, a randomised controlled study performed in pa-
tients with brain trauma found no differences in terms of
duration of mechanical ventilation, survival, or long term
sequelea between patients treated with enteral nutrition or
parenteral nutrition [39]. The prospective randomised con-
trolled EPaNIC trial [28] was conducted on 4,640 patients,
mainly with surgical patients and short-stayers, showed
the deleterious effects of the early systematic initiation of
parenteral nutrition at day 3 post-admission, preceded by
high iv 20% glucose load (day 1:400 kcal, day 2:800 kc-
al) during the first two days after admission. These de-
leterious effects were further evidenced by fewer patients
being discharged alive during the first 8 days of hospital
stay; additionally, there was an increased rate of new in-
fections, longer ICU stay and mechanical ventilation, when
compared to a late initiation of parenteral nutrition, at day
8, i.e., seven days after underfeeding in the ICU [28]. In
that context, late parenteral nutrition was more cost-effect-
ive than early parenteral nutrition [40]. In the late parenter-
al nutrition group, only 25% of patients actually received
parenteral nutrition [28]. Strict glycaemic control, shown to
be deleterious [31], was applied. In the EPaNIC trial, 89%
of patients were surgical including 60% from cardiac sur-
gery, a very rare indication of parenteral nutrition. An ex-
perimental study performed in burned rabbits suggests that
the complications of early parenteral nutrition described by
Casaer et al [28] could be secondary to autophagia defi-
cit in liver and skeletal muscle [41]. The EPaNIC trial al-
lows for the conclusion that overfeeding is deleterious at
the early phase of critical illness; and that early parenter-
al nutrition, i.e., in the 48 hours, must be avoided in sur-
gical patients, specifically if they have undergone cardi-
ac surgery. Indeed the parenteral nutrition group required
more insulin in relation to unverified energy targets and
high initial glucose load: insulin is known to be an inhibit-
or of autophagy in diabetes [42]. The later findings of the
Leuven group [41] indeed emphasize the importance of a
precise energy target – only possible with indirect calori-
metry: as a matter of fact, in the SPN trial where targets
were largely guided by indirect calorimetry, the insulin re-
quirements had not increased.
Parenteral nutrition and liver dysfunction
The use of parenteral nutrition in the ICU remains asso-
ciated with liver dysfunction in ICU patients. In a multi-
centre study which included 3,409 patients from 40 Span-
ish ICUs, Grau et al found that among the 725 patients on
artificial nutrition (total parenteral nutrition, n = 303, en-
teral nutrition, n = 422), a liver dysfunction was observed
in 23% of patients (30% in total parenteral nutrition, 18%
in enteral nutrition) [29]. In that study, three profiles of liv-
er tests were considered as liver dysfunction: (a) cholestas-
is: increased alkaline phosphatase, gamma-GT, or bilirubin
blood concentrations; (b) liver necrosis: increased transa-
minases or Quick time; (c) mixed pattern - both associ-
ated. Importantly there was no difference between the pa-
tients on enteral nutrition or parenteral nutrition during the
first 11 days, the liver dysfunction was related to non-nu-
tritional causes. In multivariate analysis, the factors associ-
ated with liver dysfunction were total parenteral nutrition,
sepsis, early enteral nutrition or parenteral nutrition, and
energy target >25 kcal/kg/day. It is noteworthy that patients
with liver dysfunction had received mostly parenteral nutri-
tion (30% vs 18% for enteral nutrition, p <0.001), and for a
longer duration than enteral nutrition (13 days [interquart-
iles 8–25] vs 8 days [interquartiles 4–16], p <0.001). These
findings clearly indicate that parenteral nutrition, initiated
early, with an energy target >25 kcal/kg/day, and lasting
more than 10 days, is associated with liver dysfunction,
probably in relation with overfeeding. Indeed it is much
easier to overfeed with parenteral nutrition than with enter-
al nutrition.
Summary
Parenteral nutrition per se does not affect mortality con-
trary to former beliefs, except in patients with severe septic
shock. Nevertheless, exclusive parenteral nutrition is asso-
ciated with an increased risk of hyperglycaemia, infections
and liver dysfunction, in relation to overfeeding. These
risks are increased by the early initiation and the duration
of parenteral nutrition, the presence of sepsis, recent sur-
gery and multifocal colonization, and by energy provision
>25 kcal/kg/day. However, the respect of good clinical
practices and academic societies’ recommendations min-
imises the risk of parenteral nutrition-related complica-
tions, and allows a safe use of parenteral nutrition.
The optimal parenteral nutrition in
clinical practice
Feeding of the patients according to energy
requirements
Indirect calorimetry is recommended to optimise the en-
ergy delivery for real needs. Future developments of this
technique of energy expenditure measurement are awaited
[43]. In the absence or unavailability of indirect calor-
imetry, the European Society for Clinical Nutrition and
Metabolism (ESPEN) recommends avoiding delivering
≥25 kcal/kg actual body weight (BW)/day during the acute
phase, and ≥30 kcal/kg actual BW/day during the post-
acute phase [1, 44]. Importantly, energy from non-nutri-
tional sources should be included in the calculations [45].
Severely malnourished patients on parenteral nutrition
should initially receive 10 kcal/kg actual BW/day, then the
target should progressively be increased to reach 25–30 kc-
al/kg actual BW/day over 3–4 days [1]. In obese or over-
weight patients, the energy requirements could be estim-
ated as 15 kcal/kg actual BW/day, or 20 kcal/kg ideal BW/
day [1, 44].
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Limitation of energy deficit and prevention of
overfeeding and hyperglycaemia
The systematic use of parenteral nutrition must be avoided.
In selected patients, i.e., with an appropriate indication,
‘all-in-one’ parenteral nutrition can be administered suc-
cessfully and safely, if it is used by a trained team [27],
if energy delivery is adapted to the energy target, if a
glycaemic control is obtained [31], and if parenteral nutri-
tion is limited through the time [8, 29]. The prevention of
overfeeding-related complications is facilitated by the fact
that the industrial parenteral nutrition solutions have con-
siderably evolved during the last two decades. They con-
tain protein, carbohydrate, lipid, and electrolytes, supple-
mented with trace elements and vitamins. They allow a
lower and constant load of glucose and lipids, reducing the
risk of hyperglycaemia, hypertriglyceridemia, and liver fat
overload. This risk has also been reduced by the increased
use of emulsions containing both long and medium chain
triglycerides. In addition, parenteral nutrition should be ad-
ministered continuously over 24h.
Glucose delivery should not exceed 6 g/kg/day, at a rate be-
low 5 mg/kg/min, and lipid supply must not exceed 23 mg/
kg/min or 60% of the total energy input. However, there is
no consensus regarding the ideal quantity of lipids. An ini-
tial supply of 0.5 to 1 g/kg/day of long chain triglycerides
seem to be best; this can be increased up to a maximum
of 2 g/kg/day if triglyceridemia and serum lactescence are
regularly monitored [27]. “Hidden” fat from the sedative
propofol should be included in the calculations [45]. The
immunosuppressive effect of standard lipid emulsions re-
mains controversial. Within the context of severe trauma/
sepsis, lipid supply is limited to about 30%–40% of non-
protein calorie input.
Indications of parenteral nutrition in ICU patients
The current indications of parenteral nutrition in ICU pa-
tients are shown in table 2. In most situations, a minimal
enteral nutrition (e.g., 250 ml/day) may contribute to main-
taining the integrity of the intestinal epithelial barrier. The
use of enteral nutrition also optimises the glycaemic con-
trol, compared to parenteral nutrition, by reducing the risk
of hyperglycaemia and decreasing insulin needs [46]. A se-
quential approach should be considered and parenteral nu-
trition should be gradually weaned over time when enter-
al nutrition reaches the energy target, to avoid overfeeding
and infectious complications of parenteral nutrition.
Monitoring of parenteral nutrition in the ICU
Table 3 proposes different strategies that could be useful
for the monitoring of parenteral nutrition during the differ-
ent phases of critical illness. Overfeeding-related metabolic
complications of parenteral nutrition must be tracked. The
monitoring of nutritional and metabolic care in the ICU has
three main goals: first, the control of the amount of de-
livered macronutrients (glucose, protein, fat) and micro-nu-
trients (vitamins and trace-elements); second, the assess-
ment of the adequation between energy needs and delivery;
finally, the glycaemic control (fig. 1). The monitoring
should be assisted by computerised systems that contribute
to optimizing energy delivery and glycaemic control [47],
thus improving adherence to guidelines and clinical out-
come. Such a goal could be achieved if computerised mon-
itoring is integrated into a global educational and interdis-
ciplinary program of nutritional care [48]. The presence of
an ICU-dedicated dietician further improves energy deliv-
ery in the ICU [48].
Fat-free mass loss is a consequence of stress, physical im-
mobilisation and energy deficit. Limited actions can be
taken for the first two factors, but energy deficit can be
prevented, thus having a positive impact on clinical out-
come and post-ICU recovery. In the future, body compos-
ition evaluation could be integrated into clinical practice,
for an early and optimised nutritional management (table
3). Clinical studies are ongoing (Phase angle project, NCT
#01907347) to assess whether specific methods, such as
bioelectrical impedance analysis and 3rd lumbar vertebra-
targeted computerised tomography, could help to assess
and monitor fat-free mass during the ICU stay. The use of
ultra-sound imaging of the thigh seems promising, hardly
invasive and with limited costs [49]. Also, the assessment
of muscle strength could be valuable, since fat-free mass
loss during the ICU stay has an impact on muscular force,
functional capacity, and therefore quality of life, during the
months following ICU discharge. Whether an optimal nu-
tritional management during the whole ICU stay could en-
hance the recovery after critical illness and improve post-
ICU muscle mass and function remains to be demonstrated.
Table 2: Indications of exclusive or supplemental parenteral nutrition (PN) in the intensive care unit (ICU) patients.
Haemodynamically stabilised patient
Post-acute phase (≥4 days post-admission): in case of EN failure or insufficiency = full oral nutrition or EN not reached within 3
days
Contra-indication to EN (within 48 hours post-admission): gastrointestinal occlusion, mesenteric ischemia, active
gastrointestinal bleeding
General indications
Acute phase (48 hours following ICU admission): avoid systematic exclusive or supplemental PN
Gastrointestinal occlusion (functional or mechanical)
Mesenteric ischemia
Active gastrointestinal bleeding
Most common situations associated with
PN use in the ICU
Intestinal insufficiency
– Short bowel syndrome: postsurgical remnant small bowel from duodeno-jejunal angulus to the most distal part of small bowel
<1.5 m
– Radiation enteritis
– Proximal (duodenum, jejunum) high output fistulae: >2 liters / 24 h)
– Inflammatory bowel diseases in acute phase
– Splanchnic ischemia
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Conclusion
In the ICU, optimal nutrition support should prevent both
energy deficit and overfeeding, thereby improving the clin-
ical outcome. Parenteral nutrition should be limited to en-
teral nutrition contraindications or failure. Parenteral nu-
trition is a safe therapy for ICU patients as long as over-
feeding and hyperglycaemia are avoided. Inadequate use
of parenteral nutrition is associated with an increased in-
fection rate and liver dysfunction. The prescription of par-
enteral nutrition to supplement insufficient enteral nutrition
(i.e., the “SPN concept”) should be initiated 24–72 hours
after ICU admission, since it results in improving clinical
outcome and cost-savings. The safe use of parenteral nu-
trition is of great interest, since it could preserve fat-free
mass in patients presenting more and more to a certain ex-
tent with clinical situations of ageing, sarcopenic obesity,
chronic diseases and pre-existing undernutrition.
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Table 3: Monitoring of PN during the different phases of critical illness.
Criteria Objective Evaluation methods Period of ICU stay
Measurement of energy
expenditure by indirect calorimetry
If available, at postacute and
rehabilitation phases
Energy target Prevention of energy deficit
Predictive formulas At any time, during the 48h post-
admission, and at postacute and
rehabilitation phases
Protein target Prevention of energy and protein
deficit
Predictive formulas At any time, during the 48h post-
admission, and at postacute and
rehabilitation phases
Macro-nutrients provision: total
energy, cumulated energy deficit,
provision in protein, carbohydrate,
fat
Prevention of energy and protein
deficit, and overfeeding
Monitoring sheet
Computerised software
Several times daily to tailor
nutrition support according to
delivery and target
Adequation between
nutritional provision and
target
Micro-nutrients provision: vitamins
and trace-elements
Prevention of micronutrient
deficiency and optimization of
macronutrient metabolism
Monitoring sheet
Computerised software
Daily
Glycaemia Prevention of overfeeding and
hypoglycaemia
Venous, arterial, or capillary blood
collection
Several times daily at the acute
phase, then daily adaptation
Glycaemic control
Insulin doses Prevention of overfeeding and
hypoglycaemia
Monitoring sheet
Computerized software
Dynamic therapeutical algorithm
Several times daily at the acute
phase, then daily adaptation
Blood sodium, potassium,
phosphates, magnesium, urea,
creatinin
Prevention of refeeding syndrome Venous blood collection
Liver tests Prevention of overfeeding and
PN-related liver disease
Venous blood collection
At the initiation of nutritional
support, then daily if abnormalities
then at least several times a week
a nutrition
Biological monitoring
Albumin / Transthyretin Follow up of nutritional status in
the absence of inflammation
Venous blood collection Weekly during the post-acute and
the rehabilitation phases
Not at the acute phase because of
inflammation
Weight: weighing bed or chair-
weigh scale
Post-acute and rehabilitation
phases
Not at the acute phase because of
hydration variations
Weight, weight loss, body mass
index
Evaluation of nutritional status
Height: heel-knee distance Post-acute and rehabilitation
phases
Fat-free mass, fat mass, total ±
intra- and extra-cellular water
Evaluation of body composition
including fat-free mass loss
(nutritional status)
Bioimpedance analysis Absence of fluid retention
Post-acute and rehabilitation
phases
Phase angle Evaluation of clinical prognosis?
(under evaluation)
Bioimpedance analysis At any time?
(under evaluation)
Skeletal muscular mass index Evaluation of body composition
including fat-free mass loss
(nutritional status)
Third lumbar vertebrae-targeted
computerised tomography
At each abdominal routine scan?
(under evaluation)
Muscular strength Evaluation of muscular function Dynamometer Post-ICU rehabilitation phase
Body composition
assessment
Quality of life Evaluation of overall health and
muscular function
Specific questionnaires Post-ICU rehabilitation phase
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Figures (large format)
Figure 1
Improved clinical outcome with optimised nutrition support and monitoring in the intensive care unit. Enteral nutrition (EN) alone is often
associated with an insufficient energy provision, leading to energy deficit; the latter is associated with fat-free mass loss, increased risk of
infections and complications, and increased mortality. Systematic parenteral nutrition (PN) without appropriate indication is associated with
increased risks of overfeeding, hyperglycaemia, and promotes infections, hepatic steatosis, liver disease, hypoglycaemia (as a result of high
insulin doses), and mortality. Optimal nutrition support improves the clinical outcome. It includes the adequate choice of nutritional support: i) EN
in first line, then together with supplemental parenteral nutrition in case of failure or contraindication to optimised EN; ii) parenteral nutrition
alone when appropriate with respect to the indications, the preferred use of ‘all-in-one’ solutions, and the glycaemic control; iii) the nutritional
and metabolic monitoring: adequation of protein/energy provision towards target, blood glucose and insulin doses according to on-going
protocols. The assessment of fat-free mass may become the key part of the nutritional management of ICU patients, but validation studies are
needed.
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